Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)

SHE:001367 Revenue

Zhejiang Haisen Pharmaceutical had revenue of 107.19M CNY in the quarter ending March 31, 2026, a decrease of -9.53%. This brings the company's revenue in the last twelve months to 520.97M, up 9.87% year-over-year. In the year 2025, Zhejiang Haisen Pharmaceutical had annual revenue of 532.26M with 12.88% growth.

• Revenue (ttm): 520.97M
• Revenue Growth: +9.87%
• P/S Ratio: 6.83
• Revenue / Employee: 738.97K
• Employees: 705
• Market Cap: 3.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	532.26M	60.75M	12.88%
Dec 31, 2024	471.51M	74.06M	18.63%
Dec 31, 2023	397.45M	-25.32M	-5.99%
Jan 1, 2023	422.78M	33.79M	8.69%
Dec 31, 2021	388.98M	104.18M	36.58%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 3, 2026

Data Sources Report a data error